Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 23 medicines
SFDA · 16 medicines · Historical list
AEMPS · 8 medicines
CBG-MEB · 6 medicines
HSA · 6 medicines
AIFA · 4 medicines
PHARMAC · 3 medicines
ALIMS · 2 medicines
TFDA · 2 medicines · Historical list
HALMED · 1 medicine
MS · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
24 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tretinoin | United States | 10MG | capsule | Marketed | Barr Labs INC |
| Tretinoin | United States | 0.025%, 0.0375%, 0.05% … | cream | Marketed | Encube |
| Tretinoin | United States | 0.01%, 0.025%, 0.04% … | gel | Marketed | Rising |
| Tretinoin | United States | 0.05% | solution | Not marketed | Teva Pharms |
| Tretinoin Microsphere | United States | 0.06%, 0.08% | gel | Marketed | Encube |
| Clindamycin Phosphate and TretinoinCombination | United States | 1.2%; 0.025% | gel | Marketed | Actavis Mid Atlantic |
| Retin-A | United States | 0.025%, 0.05%, 0.1% | cream | Marketed | Valeant Pharms North |
| Retin-A | United States | 0.01%, 0.025% | gel | Marketed | Valeant Intl |
| Retin-A Micro | United States | 0.04%, 0.1% | gel | Marketed | Bausch |
| Retin-A-Micro | United States | 0.06%, 0.08% | gel | Marketed | Bausch |
| Altreno | United States | 0.05% | lotion | Marketed | Dow Pharm |
| Atralin | United States | 0.05% | gel | Marketed | Dow Pharm |
| Retin-A | United States | 0.05% | solution | Not marketed | Valeant Intl |
| Retin-A | United States | 0.05% | swab | Not marketed | Valeant Intl |
| Avita | United States | 0.025% | cream | Marketed | Mylan Pharms INC |
| Renova | United States | 0.02%, 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream | Marketed | Valeant Pharms North |
| Vesanoid | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Cheplapharm |
| Avita | United States | 0.025% | gel | Not marketed | Rising |
| TwyneoCombination | United States | 3%; 0.1% | cream | Marketed | Mayne Pharma |
| VeltinCombination | United States | 1.2%; 0.025% | gel | Marketed | Almirall |
| Tri-LumaCombination | United States | 0.01%; 4%; 0.05% | cream | Marketed | Galderma Labs LP |
| ZianaCombination | United States | 1.2%; 0.025% | gel | Marketed | Bausch |
| Isotretinoin | United States | 10MG, 20MG, 25MG … | capsule | Marketed | Upsher Smith Labs |
| SolageCombination | United States | 2%; 0.01% | solution | Not marketed | Almirall |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
Guidelines in the library that name this substance.
Recent articles that name this substance.
